Royal Bank of Canada
MREO

Royal Bank of Canada’s Mereo BioPharma MREO Stock Holding History

Royal Bank of Canada’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed – – 7448
2025
Q3 		$0 Buy
+5
New +$9 ﹤0.01% 7360
2024
Q3 		– Sell
-28
Closed – – 7210
2024
Q2 		$0 Hold
28
– – ﹤0.01% 7356
2024
Q1 		$0 Sell
28
-29
-51% -$98 ﹤0.01% 7374
2023
Q4 		$0 Buy
+57
New +$109 ﹤0.01% 7411
2023
Q3 		– Sell
-14
Closed – – 7377
2023
Q2 		$0 Sell
14
-15
-52% -$17 ﹤0.01% 7505
2023
Q1 		$0 Sell
29
-1
-3% -$1 ﹤0.01% 7322
2022
Q4 		$0 Sell
30
-215
-88% -$177 ﹤0.01% 7535
2022
Q3 		$0 Buy
245
+15
+7% +$18 ﹤0.01% 7692
2022
Q2 		$0 Buy
+230
New +$178 ﹤0.01% 7584
2021
Q4 		– Sell
-7,500
Closed -$18K – 7814
2021
Q3 		$18K Buy
7,500
+7,475
+29,900% +$19.8K ﹤0.01% 6746
2021
Q2 		$0 Buy
+25
New +$84 ﹤0.01% 7608
2021
Q1 		– Sell
-2,000
Closed -$7K – 7592
2020
Q4 		$7K Sell
2,000
-120,000
-98% -$301K ﹤0.01% 6535
2020
Q3 		$320K Buy
122,000
+47,500
+64% +$139K ﹤0.01% 4214
2020
Q2 		$228K Buy
+74,500
New +$131K ﹤0.01% 4363

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Royal Bank of Canada's MREO Position: Q4 2025 in Review

Royal Bank of Canada sold out of Mereo BioPharma (MREO) in Q4 2025, closing a stake of 5 shares.

Royal Bank of Canada first reported a position in MREO in Q2 2020 and held it in 14 quarters. The position peaked at $320K in Q3 2020. 70 funds tracked by Wall St. Rank hold MREO as of Q4 2025.

  • Royal Bank of Canada reported no remaining Mereo BioPharma position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 5 Mereo BioPharma shares in Q4 2025.
  • Royal Bank of Canada first reported a position in Mereo BioPharma in Q2 2020 and held it in 14 quarters.
  • Royal Bank of Canada's Mereo BioPharma position peaked at $320K in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.